Zerodol Gel contains Aceclofenac (NA), a non-steroidal anti-inflammatory drug (NSAID) formulated for topical application to provide effective relief from pain and inflammation associated with musculoskeletal conditions. Aceclofenac acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins, which are mediators of inflammation and pain. Zerodol Gel is commonly prescribed for the management of acute and chronic musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains, strains, and sports-related injuries. The topical gel formulation allows for localized drug delivery, minimizing systemic exposure and reducing the risk of gastrointestinal side effects commonly associated with oral NSAIDs. It is typically applied to the affected area two to three times daily, with a thin layer gently massaged until fully absorbed. Patients should avoid applying the gel on broken or irritated skin and refrain from contact with eyes or mucous membranes. While generally well-tolerated, Zerodol Gel may cause mild local reactions such as itching or redness in some individuals. It is contraindicated in patients with known hypersensitivity to Aceclofenac or other NSAIDs. Consultation with a healthcare professional is advised before use, especially in pregnant or breastfeeding women and individuals with pre-existing medical conditions.